RT Journal Article
T1 Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.
A1 Romero-Laorden, N
A1 Piñeiro-Yañez, E
A1 Gutierrez-Pecharroman, A
A1 Pacheco, M I
A1 Calvo, E
A1 Al-Shahrour, F
A1 Castro, E
A1 Olmos, D
YR 2017
FD 2017
LK http://hdl.handle.net/10668/11146
UL http://hdl.handle.net/10668/11146
LA en
DS RISalud
RD Apr 18, 2025